Skip to main navigation
Skip to search
Skip to main content
Albert Einstein College of Medicine Home
Home
Faculty
Departments
Grants
Publications
Prizes
Search by expertise, name or affiliation
Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial
SONAR Committees and Investigators
Medicine
Research output
:
Contribution to journal
›
Article
›
peer-review
387
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Atrasentan
100%
Chronic Renal Insufficiency
54%
Type 2 Diabetes Mellitus
44%
Placebos
40%
Randomized Controlled Trials
40%
Kidney
31%
Endothelin Receptor Antagonists
15%
Creatinine
14%
Psychology Retention
13%
Glomerular Filtration Rate
11%
Chronic Kidney Failure
10%
Albumins
10%
Endothelin A Receptor Antagonists
8%
Urine
8%
Albuminuria
6%
Safety
6%
Body Surface Area
6%
Double-Blind Method
5%
Kidney Transplantation
5%
Intention
5%
Renal Insufficiency
5%
Dialysis
5%
Anemia
4%
Sodium
4%
Therapeutics
4%
Psychological Inhibition
4%
Heart Failure
4%
Research Personnel
4%
Serum
2%
Population
2%